Different Doses of Dexmedetomidine Combined With Esketamine in Women Undergoing Cesarean Delivery

PHASE4CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

October 8, 2024

Primary Completion Date

December 2, 2024

Study Completion Date

December 9, 2024

Conditions
Cesarean DeliveryEsketamineNeuropsychiatric SymptomsDexmedetomidine
Interventions
DRUG

Esketamine 0.2 mg/kg

Esketamine 0.2 mg/kg is diluted in 20 ml normal saline and infused over 40 minutes after clamping the umbilical cord.

DRUG

Esketamine 0.2 mg/kg + dexmedetomidine 0.1 µg/kg

A mixture of esketamine 0.2 mg/kg and dexmedetomidine 0.1 µg/kg is diluted in 20 ml normal saline and infused over 40 minutes after clamping the umbilical cord.

DRUG

Esketamine 0.2 mg/kg + dexmedetomidine 0.15 µg/kg

A mixture of esketamine 0.2 mg/kg and dexmedetomidine 0.15 µg/kg is diluted in 20 ml normal saline and infused over 40 minutes after clamping the umbilical cord.

DRUG

Esketamine 0.2 mg/kg + dexmedetomidine 0.2 µg/kg

A mixture of esketamine 0.2 mg/kg and dexmedetomidine 0.2 µg/kg is diluted in 20 ml normal saline and infused over 40 minutes after clamping the umbilical cord.

Trial Locations (1)

100034

Peking University First Hospital, Beijing

All Listed Sponsors
lead

Peking University First Hospital

OTHER

NCT06613243 - Different Doses of Dexmedetomidine Combined With Esketamine in Women Undergoing Cesarean Delivery | Biotech Hunter | Biotech Hunter